GeneproDX has reached an agreement with Belgium’s Biocartis for the distribution of ThyroidPrint, a test that avoids unnecessary diagnostic surgeries and the permanent use of thyroid hormone supplements.
FDI news | Policies & Tools | Business data analysis | Investment location trends
GeneproDX has reached an agreement with Belgium’s Biocartis for the distribution of ThyroidPrint, a test that avoids unnecessary diagnostic surgeries and the permanent use of thyroid hormone supplements.
Topics: Innovation- Science- Biotech
Read MoreReceive in your e-mail publications and news about how to guide your investment project in Chile
100% Privacy. No Spam.
1.449 Libertador Bernardo O'Higgins Avenue
Santiago Downtown
Tower 7, 15th Floor. Santiago, Chile
Phone: (56-2) 2663 9200